Christy A. Harrison
University of Arizona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christy A. Harrison.
Inflammatory Bowel Diseases | 2015
Rita–Marie T. McFadden; Claire B. Larmonier; Kareem W. Shehab; Monica T. Midura-Kiela; Rajalakshmy Ramalingam; Christy A. Harrison; David G. Besselsen; John Chase; J. Gregory Caporaso; Christian Jobin; Fayez K. Ghishan; Pawel R. Kiela
Background:Intestinal microbiota influences the progression of colitis-associated colorectal cancer. With diet being a key determinant of the gut microbial ecology, dietary interventions are an attractive avenue for the prevention of colitis-associated colorectal cancer. Curcumin is the most active constituent of the ground rhizome of the Curcuma longa plant, which has been demonstrated to have anti-inflammatory, antioxidative, and antiproliferative properties. Methods:Il10−/− mice on 129/SvEv background were used as a model of colitis-associated colorectal cancer. Starting at 10 weeks of age, wild-type or Il10−/− mice received 6 weekly intraperitoneal injections of azoxymethane (AOM) or phosphate-buffered saline (PBS) and were started on either a control or a curcumin-supplemented diet. Stools were collected every 4 weeks for microbial community analysis. Mice were killed at 30 weeks of age. Results:Curcumin-supplemented diet increased survival, decreased colon weight/length ratio, and, at 0.5%, entirely eliminated tumor burden. Although colonic histology indicated improvement with curcumin, no effects of mucosal immune responses have been observed in PBS/Il10−/− mice and limited effects were seen in AOM/Il10−/− mice. In wild-type and in Il10−/− mice, curcumin increased bacterial richness, prevented age-related decrease in alpha diversity, increased the relative abundance of Lactobacillales, and decreased Coriobacterales order. Taxonomic profile of AOM/Il10−/− mice receiving curcumin was more similar to those of wild-type mice than those fed control diet. Conclusions:In AOM/Il10−/− model, curcumin reduced or eliminated colonic tumor burden with limited effects on mucosal immune responses. The beneficial effect of curcumin on tumorigenesis was associated with the maintenance of a more diverse colonic microbial ecology.
PLOS ONE | 2016
Daniel Laubitz; Christy A. Harrison; Monica T. Midura-Kiela; Rajalakshmy Ramalingam; Claire B. Larmonier; John Chase; J. Gregory Caporaso; David G. Besselsen; Fayez K. Ghishan; Pawel R. Kiela
Inflammatory bowel diseases (IBD) are associated with functional inhibition of epithelial Na+/H+ exchange. In mice, a selective disruption of NHE3 (Slc9a3), a major apical Na+/H+ exchanger, also promotes IBD-like symptoms and gut microbial dysbiosis. We hypothesized that disruption of Na+/H+ exchange is necessary for the development of dysbiosis, which promotes an exacerbated mucosal inflammatory response. Therefore, we performed a temporal analysis of gut microbiota composition, and mucosal immune response to adoptive T cell transfer was evaluated in Rag2-/- and NHE3-/-/Rag2-/- (DKO) mice with and without broad-spectrum antibiotics. Microbiome (16S profiling), colonic histology, T cell and neutrophil infiltration, mucosal inflammatory tone, and epithelial permeability were analyzed. In adoptive T cell transfer colitis model, Slc9a3 status was the most significant determinant of gut microbial community. In DKO mice, NHE3-deficiency and dysbiosis were associated with dramatically accelerated and exacerbated disease, with rapid body weight loss, increased mucosal T cell and neutrophil influx, increased mucosal cytokine expression, increased permeability, and expansion of CD25-FoxP3+ Tregs; this enhanced susceptibility was alleviated by oral broad-spectrum antibiotics. Based on these results and our previous work, we postulate that epithelial electrolyte homeostasis is an important modulator in the progression of colitis, acting through remodeling of the gut microbial community.
Nature Reviews Immunology | 2017
Christy A. Harrison; Douglas Taren
Here, we discuss the link between nutrition, non-communicable chronic diseases and socio-economic standing, with a special focus on the microbiota. We provide a theoretical framework and several lines of evidence from both animal and human studies that support the idea that income inequality is an underlying factor for the maladaptive changes seen in the microbiota in certain populations. We propose that this contributes to the health disparities that are seen between lower-income and higher-income populations in high-income countries.
Mucosal Immunology | 2018
Christy A. Harrison; Daniel Laubitz; Christina L. Ohland; Monica T. Midura-Kiela; Karuna Patil; David G. Besselsen; Deepa R. Jamwal; Christian Jobin; Fayez K. Ghishan; Pawel R. Kiela
Intestinal epithelial Na+/H+ exchange facilitated by the apical NHE3 (Slc9a3) is a highly regulated process inhibited by intestinal pathogens and in inflammatory bowel diseases. NHE3−/− mice develop spontaneous, bacterially mediated colitis, and IBD-like dysbiosis. Disruption of epithelial Na+/H+ exchange in IBD may thus represent a host response contributing to the altered gut microbial ecology, and may play a pivotal role in modulating the severity of inflammation in a microbiome-dependent manner. To test whether microbiome fostered in an NHE3-deficient environment is able to drive mucosal immune responses affecting the onset or severity of colitis, we performed a series of cohousing experiments and fecal microbiome transplants into germ-free Rag-deficient or IL-10−/− mice. We determined that in the settings where the microbiome of NHE3-deficient mice was stably engrafted in the recipient host, it was able accelerate the onset and amplify severity of experimental colitis. NHE3-deficiency was characterized by the reduction in pH-sensitive butyrate-producing Firmicutes families Lachnospiraceae and Ruminococcaceae (Clostridia clusters IV and XIVa), with an expansion of inflammation-associated Bacteroidaceae. We conclude that the microbiome fostered by impaired epithelial Na+/H+ exchange enhances the onset and severity of colitis through disruption of the gut microbial ecology.
Journal of Crohns & Colitis | 2018
Christy A. Harrison; Daniel Laubitz; Monica T. Midura-Kiela; Deepa R. Jamwal; David G. Besselsen; Fayez K. Ghishan; Pawel R. Kiela
Background Broad-spectrum antibiotics [Abx], including combination therapy with ciprofloxacin and metronidazole, are often prescribed during the treatment of inflammatory bowel disease [IBD] to alleviate symptoms, but with varying success. In this pilot study, we studied the effects of Abx on the course of experimental colitis, with a particular focus on sex as a determinant of the microbial and inflammatory responses. Methods The effects of Abx were tested on colonic inflammation and microbiome in male and female Rag-/- mice, using adoptive transfer of naïve T cells to induce colitis in a short-term [2-week] and long-term [9-week] study. Results We observed disparities between the sexes in both the response to adoptive T cell transfer and the effects of Abx. At baseline without Abx, female mice displayed a trend toward a more severe colitis than males. In both the short- and the long-term experiments, gut microbiota of some female mice exposed to Abx showed weak, delayed, or negligible shifts. Caecum weight was significantly lower in Abx-treated females. Abx exposure favoured a quick and persistent rise in Enterococcaceae exclusively in females. Males had higher relative abundance of Lactobacillaceae following Abx exposure relative to females. Abx-treated females trended toward higher colitis scores than Abx-treated males, and towards higher levels of IL-17A, NOS2, and IL-22. Conclusions Although preliminary, our results suggest a differential response to both inflammation and Abx between male and female mice, The findings may be relevant to current practice and also as the basis for further studies on the differential gender effects during long-term antibiotic exposure in IBD.
Gastroenterology | 2014
Rita-Marie T. McFadden; Claire B. Larmonier; Monica T. Midura-Kiela; Rajalakshmy Ramalingam; Christy A. Harrison; David G. Besselsen; John Chase; Gregory Caporaso; Fayez K. Ghishan; Pawel R. Kiela
Gastroenterology | 2018
Vanessa R. Figliuolo da Paz; Deepa R. Jamwal; Christy A. Harrison; Daniel Laubitz; Monica T. Midura-Kiela; Fayez K. Ghishan; Pawel R. Kiela
Gastroenterology | 2018
Christy A. Harrison; Daniel Laubitz; Deepa R. Jamwal; Monica T. Midura-Kiela; Fayez K. Ghishan; Pawel R. Kiela
Gastroenterology | 2018
Michael A. Gurney; Daniel Laubitz; Christy A. Harrison; Fayez K. Ghishan; Pawel R. Kiela
Gastroenterology | 2018
Deepa R. Jamwal; Daniel Laubitz; Christy A. Harrison; Christopher M. Cox; Monica T. Midura-Kiela; Michael A. Gurney; Lonnie P. Lybarger; Jean M. Wilson; Fayez K. Ghishan; Pawel R. Kiela